Connect With a Global Community of 90+ Glioblastoma Experts
What to Expect?
Shake Hands with the Who’s Who of Glioblastoma Drug Development
Gain unparalleled opportunities for high-level networking
with influential decision-makers and pioneers driving the future
of GBM research and treatment innovation. This
event stands as the exclusive forum entirely dedicated to
glioblastoma, making it your premium destination for demonstrating your thought-leadership to experts in the field.
Showcase Your Solutions
With the field facing unique hurdles and an urgent demand for solutions, the market is open to novel approaches, and this event offers a prime stage to demonstrate how your preclinical models, delivery solutions, diagnostic technology and research solutions can provide essential insights, support drug development, and improve treatment outcomes, positioning your solutions as key to advancing the field.
Raise Your Brand Awareness
Position your brand in front of key neuro-oncology professionals who are actively seeking innovative services, unlocking new business prospects and fostering valuable connections with industry leaders.
Gain Investor Buy-In
Are you a biotech looking to fundraise? Position yourself as a partner of this meeting to receive elevated branding and exclusive networking opportunities with high-profile investors in the GBM field.
Key Services & Solutions
As the only event exclusively dedicated to glioblastoma drug development, this conference offers an unparalleled opportunity for industry leaders to engage with top experts from every corner of the GBM space. Attendees include key figures from large pharma, biotech, neuro-oncology, clinical practice, investment, and academia—all focused on driving progress in glioblastoma treatment. With a growing demand for innovative models, diagnostics, and delivery technologies, this forum is the ideal setting to identify market gaps that products and services could address.
Recent breakthroughs in the field, such as the promising results for Kite pharma in extending survival and the advancements in dual-target CAR T-cell therapy that are slowing tumor growth, have sparked renewed optimism within the GBM research community. As the field approaches a critical turning point, there is momentum for a major shift in how glioblastoma and other CNS tumors are treated.
This event provides a unique chance to position companies at the forefront of these developments, aligning with the most cutting-edge research and development in neuro-oncology. It is the perfect moment to establish valuable partnerships and showcase contributions to advancing transformative solutions for one of the most challenging areas of oncology. Join us and become part of a movement that is changing the future of GBM treatment.

Key Interest Areas
Biotechs
Contract Research Organizations
Diagnostic Providers
Brain Imaging Companies
CNS Model Providers
Hear What Our Past Sponsors Have to Say

Tremendous educational content and networking!
Senior Vice President, Belay Diagnostics

The Hansonwade series of conferences are always of exceptional high quality!
Director – Oncology Search & Evaluation, Merck

High caliber industry attendees and information. Trevor and Charlotte from Hanson Wade are exceptionally helpful, always remaining cheerful, even in challenging conditions.
CEO, Pacific Marine Biotech
Attending Companies Include

Available Inventory
We have a range of inventory from standard booth and speaking slots to more bespoke deliverables such as lanyards, exclusive dinners and tours to help elevate your brand.

Presenting Slots

Panel Discussions

Exhibition Booths

Full Delegate List

Branding Opportunities

Networking Options

Drinks Reception

Bespoke Options
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.

Jake Waring
Partnerships Director